Season 2 Episode 18- Proactive Symptom Management in Myelofibrosis
On today’s episode of The PQI Podcast we welcome Kristyn DiSogra, PharmD, BCOP and Justin Arnall, PharmD, BCOP. Dr. DiSogra and Dr. Arnall worked on a myelofibrosis quality improvement project while clinical pharmacists with the Atrium Health Specialty Pharmacy Service in Charlotte, North Carolina.
Dr. DiSogra completed her PGY1 residency at Mayo Clinic Hospital and her PGY2 oncology residency at the University of Washington after graduating from the UNC Eshelman School of Pharmacy. She joined the CMC team in January 2019 after two years with the University of Washington Medical Center/Seattle Cancer Care Alliance as an inpatient Hematopoietic Stem Cell Transplant and inpatient Hematology/Oncology Clinical Pharmacy Specialist. Her professional interests include hematology, oncology, hematopoietic stem cell transplantation, international health, and antimicrobial stewardship in cancer patients. She is currently taking time away from pharmacy and fulfilling the most important role of mother.
Dr. Arnall completed his PGY1 and PGY2 oncology residency training at Wake Forest Baptist Medical Center after graduating from the UNC Eshelman School of Pharmacy. Since completing his residency, he has practiced in malignant hematology and bone marrow transplant in both inpatient and outpatient roles. In his current role he works with both non-malignant and malignant hematologic conditions and coordinates the bleeding disorders and non-malignant hematology service line for the specialty pharmacy and rounds daily with the hematology consult team at the primary referral site for the Charlotte Metro health system.
Today we discuss myelofibrosis, Atrium Health’s myelofibrosis quality improvement project, the Proactive Symptom Management in Myelofibrosis PQI, and how other clinics can implement this telehealth-based project.